Identification and characterization of the acidic pH binding sites for growth regulatory ligands of low density lipoprotein receptor-related protein-1.

The Journal of Biological Chemistry
Thai-Yen LingJung San Huang

Abstract

The type V TGF-beta receptor (TbetaR-V) plays an important role in growth inhibition by IGFBP-3 and TGF-beta in responsive cells. Unexpectedly, TbetaR-V was recently found to be identical to the LRP-1/alpha(2)M receptor; this has disclosed previously unreported growth regulatory functions of LRP-1. Here we demonstrate that, in addition to expressing LRP-1, all cells examined exhibit low affinity but high density acidic pH binding sites for LRP-1 growth regulatory ligands (TGF-beta(1), IGFBP-3, and alpha(2)M(*)). These sites, like LRP-1, are sensitive to receptor-associated protein and calcium depletion but, unlike LRP-1, are also sensitive to chondroitin sulfate and heparin and capable of directly binding ligands, which do not bind to LRP-1. Annexin VI has been identified as a major membrane-associated protein capable of directly binding alpha(2)M(*) at acidic pH. This is evidenced by: 1) structural and Western blot analyses of the protein purified from bovine liver plasma membranes by alpha(2)M(*) affinity column chromatography at acidic pH, and 2) dot blot analysis of the interaction of annexin VI and (125)I-alpha(2)M(*). Cell surface annexin VI is involved in (125)I-TGF-beta(1) and (125)I-alpha(2)M(*) binding to the acidic p...Continue Reading

References

Jun 26, 1992·Cell·J Massagué
Jan 23, 1986·Biochimica Et Biophysica Acta·J Gliemann, O Davidsen
Aug 15, 1986·The Biochemical Journal·P B Moore
Dec 1, 1984·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J L Wike-HooleyH S Reinhold
May 1, 1984·European Journal of Cancer & Clinical Oncology·J L Wike-HooleyH S Reinhold
Jan 1, 1981·Pharmacology & Therapeutics·C D Burgess
Jan 1, 1993·Methods in Enzymology·G Salvesen, J J Enghild
Sep 10, 1994·Annals of the New York Academy of Sciences·D J FitzgeraldS Leppla
Jun 22, 1994·Biochimica Et Biophysica Acta·C E TagoeJ H Walker
Jan 1, 1994·Methods in Cell Biology·D M BersR Nuccitelli
Apr 3, 1998·Mineral and Electrolyte Metabolism·A B Roberts
May 23, 1998·The Journal of Biological Chemistry·R IshitsukaI Matsumoto
Oct 6, 1998·Annual Review of Biochemistry·J Massagué
Dec 9, 1998·Current Biology : CB·J V GerasimenkoO V Gerasimenko
Nov 24, 1999·Nature Cell Biology·T E WillnowJ Herz
Apr 25, 2000·Biochemical and Biophysical Research Communications·H MuramatsuT Muramatsu
Jul 13, 2000·Proceedings of the National Academy of Sciences of the United States of America·D Rathore, T F McCutchan
Aug 26, 2000·Progress in Biophysics and Molecular Biology·J I Kourie, H B Wood
Oct 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·B J BacskaiB T Hyman
Feb 21, 2002·Trends in Endocrinology and Metabolism : TEM·Dudley K StricklandW Scott Argraves
Mar 28, 2002·Physiological Reviews·Volker Gerke, Stephen E Moss
Apr 20, 2002·Biophysical Journal·Aneta KirilenkoJoanna Bandorowicz-Pikula
Jun 5, 2002·Annual Review of Biochemistry·Joachim Herz, Hans H Bock

❮ Previous
Next ❯

Citations

May 23, 2009·Journal of Cell Science·Chun-Lin ChenJung San Huang
May 17, 2011·Atherosclerosis·Riia PlihtariKatariina Öörni
Apr 2, 2019·Frontiers in Cell and Developmental Biology·Ewa E Bres, Andreas Faissner
Jun 15, 2021·Frontiers in Cardiovascular Medicine·Jiefang ChenLing Mao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.